Literature DB >> 17964673

Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose delivery.

Paul Kuo1, Reawika Chaikomin, Amelia Pilichiewicz, Deirdre O'Donovan, Judith M Wishart, James H Meyer, Karen L Jones, Christine Feinle-Bisset, Michael Horowitz, Christopher K Rayner.   

Abstract

CONTEXT: The "incretin" hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), account for some 60% of the stimulation of insulin by oral glucose, but the determinants of their secretion from the small intestine are poorly understood. Cells which release GIP (K cells) are localized to the proximal small intestine, while GLP-1 releasing cells (L cells) predominate in the distal gut. It has been suggested that a threshold rate of duodenal glucose delivery (approximately 1.8 kcal/min) needs to be exceeded for stimulation of GLP-1.
OBJECTIVE: To determine whether a low intraduodenal glucose load (1 kcal/min) has the capacity to stimulate GLP-1, and if so, the characteristics of the response.
DESIGN: Retrospective analysis of all studies in our laboratory involving healthy humans administered intraduodenal glucose at 1 kcal/min for 120 min.
SETTING: Clinical research laboratory. PARTICIPANTS: 27 healthy subjects (24 male; age 36+/-3 years; BMI 25.2+/-0.7 kg/m(2)). MAIN OUTCOME MEASURES: Plasma GLP-1, GIP, insulin, and blood glucose concentrations, reported as mean+/-SEM.
RESULTS: During intraduodenal glucose, plasma GLP-1 increased at 15 and 30 min (P<0.001 for both) and returned to baseline thereafter. In contrast, there were sustained increases in plasma GIP (P<0.001), insulin (P<0.001), and blood glucose (P<0.001).
CONCLUSION: In healthy subjects, there is early, transient stimulation of GLP-1 by glucose loads hitherto believed to be "sub-threshold". The mechanisms underlying this effect, which could be attributed to initially rapid transit to jejunal L cells, or a duodeno-jejunoileal neural or hormonal loop, remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964673     DOI: 10.1016/j.regpep.2007.09.032

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  4 in total

Review 1.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

2.  Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gene.

Authors:  Li Niu; Yan-Cheng Xu; Zhe Dai; Hui-Qin Tang
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

Review 3.  Pharmacology and physiology of gastrointestinal enteroendocrine cells.

Authors:  O J Mace; B Tehan; F Marshall
Journal:  Pharmacol Res Perspect       Date:  2015-07-07

4.  Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats.

Authors:  Yin Lin; Kasper Krogh-Andersen; Julien Pelletier; Harold Marcotte; Claes-Göran Östenson; Lennart Hammarström
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.